Free tool
FAERS Monitor: Arthrotec
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020607 or its brand name (Arthrotec, Diclofenac Sodium, Misoprostol). Reports on generic versions are filed under their own applications.
Reports
6,640
Serious
5,019
76% of reports
Hospitalization
1,730
Death reported
306
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,203
- pain900
- arthralgia777
- rheumatoid arthritis685
- nausea634
- fatigue557
- drug hypersensitivity520
- diarrhoea518
- malaise450
- headache414
- dizziness411
- pain in extremity384
- joint swelling372
- back pain359
- dyspnoea331
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 191 |
| 2005 | 282 |
| 2006 | 249 |
| 2007 | 247 |
| 2008 | 205 |
| 2009 | 231 |
| 2010 | 381 |
| 2011 | 290 |
| 2012 | 416 |
| 2013 | 340 |
| 2014 | 276 |
| 2015 | 371 |
| 2016 | 401 |
| 2017 | 366 |
| 2018 | 443 |
| 2019 | 498 |
| 2020 | 615 |
| 2021 | 248 |
| 2022 | 222 |
| 2023 | 131 |
| 2024 | 128 |
| 2025 | 74 |
| 2026 | 35 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,519 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| rheumatoid arthritisSignal | 685 | 19.2 | 17.9 | 11,807 |
| joint swellingSignal | 372 | 9.8 | 8.9 | 2,935 |
| drug hypersensitivitySignal | 520 | 8.5 | 7.9 | 3,473 |
| arthralgiaSignal | 777 | 5.9 | 5.5 | 3,237 |
| back painSignal | 359 | 4.9 | 4.4 | 1,121 |
| painSignal | 900 | 4.6 | 4.4 | 2,645 |
| pain in extremitySignal | 384 | 4.1 | 3.7 | 920 |
| malaiseSignal | 450 | 3.3 | 3.0 | 714 |
| drug ineffectiveSignal | 1,203 | 2.9 | 2.7 | 1,586 |
| dizzinessSignal | 411 | 2.6 | 2.4 | 417 |
| diarrhoeaSignal | 518 | 2.5 | 2.3 | 498 |
| nauseaSignal | 634 | 2.5 | 2.4 | 612 |
| fatigueSignal | 557 | 2.3 | 2.1 | 408 |
| headacheSignal | 414 | 2.1 | 1.9 | 242 |
| dyspnoea | 331 | 1.9 | 1.7 | 133 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.